Login to Your Account



GOING BEYOND THE EXOME

Noncoding mutations shed some light on pancreatic tumors

By Anette Breindl
Senior Science Editor

Thursday, May 11, 2017

The first large-scale analysis of noncoding genome regions in pancreatic cancer samples has both implicated new players in pancreatic cancer and given insights into how known culprits exert their effects. Researchers from the Cold Spring Harbor Laboratory published their findings in the May 8, 2017, online issue of Nature Genetics.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription